Study to know role of Ayurveda medicines in Preventing COVID-19 infections

Phase 4

Completed

• Registration Number: CTRI/2021/07/034606
• Lead Sponsor: Sree Ramachandra Health services Pvt Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 3 April 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.People not vaccinated with any COVID Vaccine at the time of enrolment in the trial.

2.Age limit â?? 18 to 45 years, both Male & Female

3.Patients willing to give their consent to participate in the clinical trial

Exclusion Criteria

1.People vaccinated with any Covid vaccine at any point of time before enrolment in the trial.

2.People with PCR proven Covid infections within the last 3 months

3.People taking other Ayurvedic/ Siddha medicines.

4.Patients with acute renal failure or Stage 4 CKD or Liver Failure (AST/ALT >5 times elevated)

5.Patients on Immuno-suppression therapy

6.Pregnant Women or lactating mothers

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To study the effect of NF2 in the prevention of COVID-19 infectionsTimepoint: Baseline and 12 weeks

Secondary Outcome Measures

Name	Time	Method
1.Symptom severity in infected cases by Modified Jackson score on Day1, 7 and 14. <br/ ><br>2.Clinical status of infected cases on ordinal scale for Covid -19 at day 1, 7 and 14 <br/ ><br>Timepoint: Day1,7and14.